cis-Platinum in gynecologic cancer. III. Toxicity (Q33485598)

27 July 2017

title

cis-Platinum in gynecologic cancer. III. Toxicity (English)

1 reference

27 July 2017

Hall DJ

1

1 reference

27 July 2017

Diasio R

series ordinal

2

1 reference

27 July 2017

Goplerud DR

series ordinal

3

1 reference

27 July 2017

language of work or name

English

0 references

publication date

1 October 1981

1 reference

American Journal of Obstetrics and Gynecology

27 July 2017

published in

1 reference

27 July 2017

volume

141

1 reference

27 July 2017

issue

3

1 reference

27 July 2017

page(s)

309-312

1 reference

Cis-diamminedichloroplatinum (II). A new anticancer drug

27 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2816%2932638-2

Cisplatin (cis-diamminedichloroplatinum II)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2816%2932638-2

cis-Platinum ototoxicity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2816%2932638-2

High dose cis-platinum diammine dichloride: amelioration of renal toxicity by mannitol diuresis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2816%2932638-2

Preliminary clinical experience withcis-diamminedichloroplatinum (II) (NSC 119875, CACP)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2816%2932638-2

cis-Platinum in advanced gynecologic malignancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2816%2932638-2

7 January 2021

Platinum nephrotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2816%2932638-2

Peripheral neuropathy associated with cis-dichlorodiammineplatinum (II) treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2816%2932638-2

10.1016/S0002-9378(16)32638-2

7 January 2021

Identifiers

DOI

1 reference

27 July 2017

1 reference